Vivace Therapeutics Raises $35 Million Series D
March 15, 2025
March 15, 2025
PALO ALTO, California, March 15 -- Cooley, a law firm, issued the following news release:
* * *
Vivace Therapeutics Raises $35 Million Series D
Cooley advised Vivace Therapeutics, a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, on its $35 million Series D financing.
Existing investor RA Capital Management led the round, with participation from other existing investors Ca . . .
* * *
Vivace Therapeutics Raises $35 Million Series D
Cooley advised Vivace Therapeutics, a small molecule discovery and development company developing first-in-class cancer therapies targeting the Hippo pathway, on its $35 million Series D financing.
Existing investor RA Capital Management led the round, with participation from other existing investors Ca . . .